Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent

por Mohamad Anuar, Nur Najmi, Nor Hisam, Nur Syahidah, Liew, Sze Ling, Ugusman, Azizah
Publicado 2020

Combination Therapy of Navitoclax with Chemotherapeutic Agents in Solid Tumors and Blood Cancer: A Review of Current Evidence

por Nor Hisam, Nur Syahidah, Ugusman, Azizah, Rajab, Nor Fadilah, Ahmad, Mohd Faizal, Fenech, Michael, Liew, Sze Ling, Mohamad Anuar, Nur Najmi
Publicado 2021